MiNK Therapeutics is a privately held company tracked for investment-relevant business and technology developments.
This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.
Mick Therapeutics is an early-stage company the host is studying within the longevity/AI-biology convergence theme, though limited public information suggests a speculative watchlist position rather than high conviction.